# Neurophet., Inc.

- Location (FDA's records): Seoul, KR
- FDA decisions: 6 (2022–2026): 6 510(k) clearances
- Product codes: QIH (4), LLZ (2)
- 510(k) review time since 2016: median 131 days, against 134 for FDA's reviews in the same codes and years (3 of 6 faster)
- Predicates its devices cite: 8 (5 its own); citations of its devices by later devices: 6 (5 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cortechs Labs, Inc.: 2 (https://510kreport.com/company/cortechs-labs)
- Heuron Co., Ltd.: 1 (https://510kreport.com/company/heuron)

## Firms that cite its devices most
- Airs Medical, Inc.: 1 (https://510kreport.com/company/airs-medical)

## Its most-cited devices
- K221405: Neurophet SCALE PET (2022), cited by 2
- K242215: Neurophet AQUA (V3.1) (2024), cited by 2
- K220437: Neurophet AQUA (2023), cited by 1
- K252496: Neurophet AQUA AD Plus (2026), cited by 1

## Recent decisions
- K261273: Neurophet AQUA (May 15, 2026)
- K252563: Neurophet SCALE PET (May 15, 2026)
- K252496: Neurophet AQUA AD Plus (Jan 29, 2026)
- K242215: Neurophet AQUA (V3.1) (Oct 25, 2024)
- K220437: Neurophet AQUA (May 10, 2023)
- K221405: Neurophet SCALE PET (Aug 5, 2022)

Source page: https://510kreport.com/company/neurophet